Breaking News Instant updates and real-time market news.

TROW

T. Rowe Price

$100.13

1.02 (1.03%)

08:41
04/01/19
04/01
08:41
04/01/19
08:41

T. Rowe Price price target raised to $119 from $103 at Jefferies

Jefferies analyst Daniel Fannon raised his price target for T. Rowe Price to $119 from $103 and keeps a Buy rating on the shares after spending time with management. With normal seasonality as a tailwind, T. Rowe appears on track to generate industry leading organic growth in Q1, Fannon tells investors in a research note. The company's "differentiated investment performance across all relevant time periods continues to distinguish it from the peer group," adds the analyst.

  • 25

    Apr

TROW T. Rowe Price
$100.13

1.02 (1.03%)

01/14/19
FBCO
01/14/19
NO CHANGE
Target $107
FBCO
Outperform
T. Rowe Price price target lowered to $107 from $115 at Credit Suisse
Credit Suisse analyst Craig Siegenthaler lowered his price target for T. Rowe Price to $107 from $115 ahead of quarterly results. The analyst reiterates an Outperform rating on the shares.
01/14/19
SBSH
01/14/19
NO CHANGE
SBSH
Citi gets more defensive on Brokers & Asset Managers, downgrades five
Citi analyst Citi analyst William Katz is taking a more defense stance on the traditional Brokers & Asset Managers to reflect what he sees as "weak" fundamentals and "still elevated" consensus estimates. The analyst reduced his target multiples across the group and downgraded Affiliated Managers (AMG) and Brightsphere Investment Group (BSIG) to Neutral from Buy as well as Artisan Partners (APAM), Waddell & Reed (WDR) and Franklin Resources (BEN) to Sell from Neutral. Katz calls Och-Ziff Capital (OZM) and LPL Financial (LPLA) his top ideas and also opened a "30 Day Positive Catalyst Watch" for Carlyle Group (CG) and Legg Mason (LM). The analyst recommends pair trades of Overweight AllianceBernstein (AB), underweight Artisan Partners (APAM), and overweight BlackRock (BLK), underweight T. Rowe Price (TROW).
01/31/19
EVER
01/31/19
UPGRADE
EVER
Outperform
T. Rowe Price upgraded to Outperform from In Line at Evercore ISI
02/27/19
FBCO
02/27/19
NO CHANGE
Target $121
FBCO
Outperform
T. Rowe Price price target raised to $121 from $107 at Credit Suisse
Credit Suisse analyst Craig Siegenthaler raised his price target for T. Rowe Price to $121 from $107 after attending the company's 3rd Annual Investor Day. The analyst believes T. Rowe Price's investments in product, distribution and vehicles, when combined with its strong investment performance and attractively priced offerings, will all help the firm to continue to generate organic growth that is 300-400bps faster than peers. Additionally, Siegenthaler looks for expense growth to continue to decline as the pace of its investments decelerate with 4%-7% growth in 2019 comparing to 9% in 2018 and 12% in 2017. He reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

EVFM

Evofem

$5.01

-0.065 (-1.28%)

06:39
10/16/19
10/16
06:39
10/16/19
06:39
Initiation
Evofem initiated  »

Evofem assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASML

ASML

$267.56

5.73 (2.19%)

06:37
10/16/19
10/16
06:37
10/16/19
06:37
Hot Stocks
Breaking Hot Stocks news story on ASML »

ASML CEO Peter Wennink…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 19

    Nov

ASML

ASML

$267.56

5.73 (2.19%)

06:37
10/16/19
10/16
06:37
10/16/19
06:37
Earnings
ASML sees Q4 net sales around EUR3.9B »

ASML sees Q4 gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 19

    Nov

FSCT

ForeScout

$26.13

0.56 (2.19%)

06:36
10/16/19
10/16
06:36
10/16/19
06:36
Recommendations
ForeScout analyst commentary  »

ForeScout price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 12

    Dec

ASML

ASML

$267.56

5.73 (2.19%)

06:36
10/16/19
10/16
06:36
10/16/19
06:36
Earnings
ASML reports Q3 EPS EUR1.49 vs. EUR1.13 in Q2 »

Reports Q3 net sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 19

    Nov

FHN

First Horizon

$16.13

0.22 (1.38%)

06:36
10/16/19
10/16
06:36
10/16/19
06:36
Earnings
First Horizon reports Q3 adjusted EPS 43c, consensus 42c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 07

    Nov

BK

BNY Mellon

$44.37

0.47 (1.07%)

06:33
10/16/19
10/16
06:33
10/16/19
06:33
Earnings
BNY Mellon reports Q3 EPS $1.07, consensus 99c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

BLDR

Builders FirstSource

$21.54

0.96 (4.66%)

06:33
10/16/19
10/16
06:33
10/16/19
06:33
Upgrade
Builders FirstSource rating change  »

Builders FirstSource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 13

    Nov

  • 14

    Nov

NEPT

Neptune Wellness

$3.46

0.135 (4.06%)

06:33
10/16/19
10/16
06:33
10/16/19
06:33
Hot Stocks
Neptune Wellness announces Sherbrooke facility to use new cold ethanol equipment »

Neptune Wellness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

BMCH

BMC Stock Holdings

$26.15

0.94 (3.73%)

06:33
10/16/19
10/16
06:33
10/16/19
06:33
Upgrade
BMC Stock Holdings rating change  »

BMC Stock Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 13

    Nov

ALXN

Alexion

$104.85

3.455 (3.41%)

, ACHN

Achillion

$3.66

0.115 (3.25%)

06:33
10/16/19
10/16
06:33
10/16/19
06:33
Hot Stocks
Alexion to acquire Achillion for $6.30 per share in cash »

Alexion Pharmaceuticals…

ALXN

Alexion

$104.85

3.455 (3.41%)

ACHN

Achillion

$3.66

0.115 (3.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

AVGO

Broadcom

$290.46

8.81 (3.13%)

06:32
10/16/19
10/16
06:32
10/16/19
06:32
Hot Stocks
Broadcom ordered by EU to halt allegedly anticompetitive contract practices »

The European Commission…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KNX

Knight-Swift

$35.68

-0.365 (-1.01%)

06:31
10/16/19
10/16
06:31
10/16/19
06:31
Recommendations
Knight-Swift analyst commentary  »

Knight-Swift should rally…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

ALXN

Alexion

$104.85

3.455 (3.41%)

, ACHN

Achillion

$3.66

0.115 (3.25%)

06:31
10/16/19
10/16
06:31
10/16/19
06:31
Hot Stocks
Breaking Hot Stocks news story on Alexion, Achillion »

Alexion to acquire…

ALXN

Alexion

$104.85

3.455 (3.41%)

ACHN

Achillion

$3.66

0.115 (3.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

AMZN

Amazon.com

$1,768.70

31.65 (1.82%)

, ORCL

Oracle

$56.35

-0.1 (-0.18%)

06:29
10/16/19
10/16
06:29
10/16/19
06:29
Hot Stocks
Amazon says consumer business turns off final Oracle database »

Amazon (AMZN) said in a…

AMZN

Amazon.com

$1,768.70

31.65 (1.82%)

ORCL

Oracle

$56.35

-0.1 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 21

    Nov

BTI

British American Tobacco

$34.60

0.245 (0.71%)

, MO

Altria Group

$43.43

0.72 (1.69%)

06:27
10/16/19
10/16
06:27
10/16/19
06:27
Periodicals
Congress probes whether e-cig manufacturers paid for spam bots, WSJ reports »

Congress has launched an…

BTI

British American Tobacco

$34.60

0.245 (0.71%)

MO

Altria Group

$43.43

0.72 (1.69%)

IMBBY

Imperial Brands

$0.00

(0.00%)

PM

Philip Morris

$78.32

0.28 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 12

    Nov

RYAM

Rayonier Advanced Materials

$4.70

0.21 (4.68%)

06:27
10/16/19
10/16
06:27
10/16/19
06:27
Downgrade
Rayonier Advanced Materials rating change  »

Rayonier Advanced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CP

Canadian Pacific

$218.42

3.27 (1.52%)

06:26
10/16/19
10/16
06:26
10/16/19
06:26
Downgrade
Canadian Pacific rating change  »

Canadian Pacific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

RYTM

Rhythm Pharmaceuticals

$20.90

0.52 (2.55%)

06:24
10/16/19
10/16
06:24
10/16/19
06:24
Syndicate
Rhythm Pharmaceuticals 8.11M share Spot Secondary priced at $18.50 »

The deal priced inside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

PRQR

ProQR Therapeutics

$6.21

-0.09 (-1.43%)

06:23
10/16/19
10/16
06:23
10/16/19
06:23
Syndicate
ProQR Therapeutics 9.091M share Spot Secondary priced at $5.50 »

Citi and Evercore ISI…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

SSNLF

Samsung

$0.00

(0.00%)

06:23
10/16/19
10/16
06:23
10/16/19
06:23
Periodicals
Samsung places further EUV equipment orders, DigiTimes reports »

Samsung Electronics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

RYTM

Rhythm Pharmaceuticals

$20.90

0.52 (2.55%)

06:23
10/16/19
10/16
06:23
10/16/19
06:23
Syndicate
Rhythm Pharmaceuticals 8.108M share Spot Secondary priced at $18.50 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

PRNB

Principia Biopharma

$29.88

0.7 (2.40%)

06:22
10/16/19
10/16
06:22
10/16/19
06:22
Syndicate
Principia Biopharma 7.5M share Spot Secondary priced at $28.00 »

The deal priced inside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

EURN

Euronav NV

$10.72

-0.605 (-5.34%)

06:21
10/16/19
10/16
06:21
10/16/19
06:21
Recommendations
Euronav NV analyst commentary  »

Euronav a good play on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

BA

Boeing

$370.99

-2.05 (-0.55%)

, EADSY

Airbus

$0.00

(0.00%)

06:20
10/16/19
10/16
06:20
10/16/19
06:20
Periodicals
Entry date for Boeing's 777-8 depending on customer demand, Reuters reports »

The date of entry into…

BA

Boeing

$370.99

-2.05 (-0.55%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.